Skip to main content


News

News
April 14, 2021
A recent real-world study compared HCRU and costs associated with first-line ibrutinib monotherapy vs bendamustine plus rituximab for patients with CLL.
News
April 14, 2021
A recent real-world study compared HCRU and costs associated with first-line ibrutinib monotherapy vs bendamustine plus…
News
April 01, 2021
A recent study comparing brachytherapy, dose-escalated external beam radiotherapy, and stereotactic body radiation…
News
March 16, 2021
KTE-X19 is a potentially cost-effective alternative to the current standard of care for relapsed/refractory MCL.
News
March 12, 2021
Study results show adjuvant hormonal therapy adherence at 5 years are low among commercially insured patients with…
News
March 12, 2021
A methodology to identify high-value oncology care was developed using cost of care per patient per day in breast…
News
March 10, 2021
Testing a limited, clinically relevant subset of genes may optimize genetic testing for women diagnosed with ovarian or…
News
March 02, 2021
Study results show nivolumab monotherapy is effective for previously treated advanced NSCLC in real-world practice.
News
February 19, 2021
Study suggests provider characteristics, like gender and geographic region may play a role in predicting treatment…
News
February 17, 2021
Acalabrutinib demonstrated favorable PFS and OS compared with standard first-line treatments for CLL, according to a…
News
February 15, 2021
Higher out-of-pocket costs for TKIs are associated with decreased therapy adherence among patients with EGFR- and ALK-…
Back to Top